Selective binding of a bioactive porphyrin-based photosensitizer to the G-quadruplex from the KRAS oncogene promoter.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 29 08 2019
revised: 07 10 2019
accepted: 17 12 2019
pubmed: 25 12 2019
medline: 21 11 2020
entrez: 25 12 2019
Statut: ppublish

Résumé

The G-quadruplex-forming sequence within the KRAS proto-oncogene P1 promoter is a promising target for anticancer therapy. Porphyrin derivatives are among the most rewarding G-quadruplex binders. They can also behave as photosensitizers. Three water-soluble, positively charged porphyrin-like compounds were synthesized and tested for their interaction with the KRAS G-quadruplex by circular dichroism, fluorescence, and molecular docking calculations. For a comparison of ligands binding affinity and selectivity, TMPyP4 was taken as a reference. One out of the three tested compounds proved biological activity and selectivity for G-quadruplex over duplex DNA. It also showed to discriminate between different G-quadruplex topologies, with a preference for the parallel over antiparallel conformation. Molecular docking studies suggested a preferential binding to the 3'-end of the KRAS G-quadruplex driven through π-π stacking interactions. Biological assays also revealed a good photodynamic-induced cytotoxicity on HeLa cells. The reported results show that these porphyrin-like compounds could actually give the basis for the development of G-quadruplex ligands with effective photodynamic-induced cytotoxicity on cancer cells. The possibility of obtaining photosensitizers with improved physico-chemical features and able to selectively target G-quadruplexes is a very interesting perspective to develop new therapeutic agents.

Sections du résumé

BACKGROUND BACKGROUND
The G-quadruplex-forming sequence within the KRAS proto-oncogene P1 promoter is a promising target for anticancer therapy. Porphyrin derivatives are among the most rewarding G-quadruplex binders. They can also behave as photosensitizers.
METHODS METHODS
Three water-soluble, positively charged porphyrin-like compounds were synthesized and tested for their interaction with the KRAS G-quadruplex by circular dichroism, fluorescence, and molecular docking calculations. For a comparison of ligands binding affinity and selectivity, TMPyP4 was taken as a reference.
RESULTS RESULTS
One out of the three tested compounds proved biological activity and selectivity for G-quadruplex over duplex DNA. It also showed to discriminate between different G-quadruplex topologies, with a preference for the parallel over antiparallel conformation. Molecular docking studies suggested a preferential binding to the 3'-end of the KRAS G-quadruplex driven through π-π stacking interactions. Biological assays also revealed a good photodynamic-induced cytotoxicity on HeLa cells.
CONCLUSIONS CONCLUSIONS
The reported results show that these porphyrin-like compounds could actually give the basis for the development of G-quadruplex ligands with effective photodynamic-induced cytotoxicity on cancer cells.
GENERAL SIGNIFICANCE CONCLUSIONS
The possibility of obtaining photosensitizers with improved physico-chemical features and able to selectively target G-quadruplexes is a very interesting perspective to develop new therapeutic agents.

Identifiants

pubmed: 31870869
pii: S0141-8130(19)36977-6
doi: 10.1016/j.ijbiomac.2019.12.152
pii:
doi:

Substances chimiques

KRAS protein, human 0
Ligands 0
MAS1 protein, human 0
Oligonucleotides 0
Photosensitizing Agents 0
Porphyrins 0
Proto-Oncogene Mas 0
Water 059QF0KO0R
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

244-251

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Marco Caterino (M)

Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy.

Federica D'Aria (F)

Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy.

Andrey V Kustov (AV)

Krestov Institute of Solution Chemistry of Russian Academy of Sciences, Ivanovo, Russian Federation; Ivanovo State University of Chemistry and Technology, Institute of Macroheterocyclic Compounds, Ivanovo, Russian Federation.

Dmitrii V Belykh (DV)

Institute of Chemistry of Komi Science Center of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Russian Federation.

Irina S Khudyaeva (IS)

Institute of Chemistry of Komi Science Center of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Russian Federation.

Olga M Starseva (OM)

Institute of Chemistry of Komi Science Center of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Russian Federation.

Dmitriy B Berezin (DB)

Ivanovo State University of Chemistry and Technology, Institute of Macroheterocyclic Compounds, Ivanovo, Russian Federation.

Yana I Pylina (YI)

Institute of Biology of Komi Scientific Center of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Russian Federation.

Tatiana Usacheva (T)

Ivanovo State University of Chemistry and Technology, Department of General Chemical Technology, Ivanovo, Russian Federation.

Jussara Amato (J)

Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy. Electronic address: jussara.amato@unina.it.

Concetta Giancola (C)

Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy. Electronic address: giancola@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH